WO2023218430 - METHODS OF TREATING RETINAL DEGENERATIVE DISEASES USING AIMP2-DX2 AND OPTIONALLY A TARGET SEQUENCE FOR MIR‑142 AND COMPOSITIONS THEREOF
National phase entry:
Publication Number
WO/2023/218430
Publication Date
16.11.2023
International Application No.
PCT/IB2023/054956
International Filing Date
13.05.2023
Title **
[English]
METHODS OF TREATING RETINAL DEGENERATIVE DISEASES USING AIMP2-DX2 AND OPTIONALLY A TARGET SEQUENCE FOR MIR‑142 AND COMPOSITIONS THEREOF
[French]
MÉTHODES DE TRAITEMENT DE MALADIES DÉGÉNÉRATIVES DE LA RÉTINE UTILISANT AIMP2-DX2 ET ÉVENTUELLEMENT UNE SÉQUENCE CIBLE POUR MIR142 ET COMPOSITIONS ASSOCIÉES
Applicants **
GENEROATH CO., LTD.
Inventors
CHOI, Jin Woo
BAEK, Kyunghwa
Priority Data
63/341,798
13.05.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
MOIP
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3020 | |
| EPO | Filing, Examination, Granting | 19127 | |
| Japan | Filing, Examination, Granting | 2591 | |
| South Korea | Filing, Examination, Granting | 2215 | |
| USA | Filing, Examination, Granting | 6390 |
Total:
33,343
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Disclosed herein are methods of treating retinal degenerative diseases, comprising administering to a subject in need thereof a vector comprising AIMP2-DX2 and optionally a target sequence for miR-142.[French]
Sont présentement divulguées des méthodes de traitement de maladies dégénératives de la rétine, comprenant l'administration à un sujet qui en a besoin d'un vecteur comprenant AIMP-DX2 et éventuellement une séquence cible pour miR-142.